And today we are green with the rest of the market. There is some biotech news but at this point the sector is trading simply as a slightly higher beta.
China and trade seemed to be fading into the background potentially setting this week up for a decline of the highly correlated macro markets but Iran and the Middle East.
Well, yesterday ending up being a good day with the XBI eventually following the individual stocks but this continues to be a highly correlated macro market. The broader market seems.
Macro seems to once again dominate the trading with both Iran and China increasing the risk and both North Korea and Venezuela just below the surface. The odds remain that.
The sector really is trading without a clear trend. Nothing that has happened this week has created a new trend but the range is narrowing, so I expect next week.
The sector remains in a rut. The market is doing well with the bio-pharma the clear laggard. While the mania over the medicare for all worry seems to have abated,.
Yesterday really ended up offering no real direction. We could not quite rally but we also did not quite collapse. Everything that I talked about yesterday about the trading of.
Yesterday was good but not a good start to today. We were certainly due for a bounce and we should be looking for signs as to the next move. The.
The trend in the sector is moving onto more and more shaky ground. Breaking below $86.22 on the XBI (the most recent low) would end the streak of higher highs.
Certainly an interesting start to the week. In terms of the broader sector, I suspect that we have a positive week as we are in the area where a bounce.
We are starting to get some news (from EASL) but still nothing that appears compelling for the sector. Sure, these are going to be potentially stock moving but it appears.